Cargando…
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
PURPOSE: To evaluate the feasibility of the use of real-time magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided high-dose-rate brachytherapy (HDR-BT) +/– external beam radiation therapy (EBRT) in patients with histologically-proven local relapse after radical prostatectomy....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241376/ https://www.ncbi.nlm.nih.gov/pubmed/28115952 http://dx.doi.org/10.5114/jcb.2016.64441 |
_version_ | 1782496176470228992 |
---|---|
author | Buchser, David Gomez-Iturriaga, Alfonso Melcon, J. Ignacio Rodriguez Casquero, Francisco Llarena, Roberto Cacicedo, Jon Bilbao, Pedro |
author_facet | Buchser, David Gomez-Iturriaga, Alfonso Melcon, J. Ignacio Rodriguez Casquero, Francisco Llarena, Roberto Cacicedo, Jon Bilbao, Pedro |
author_sort | Buchser, David |
collection | PubMed |
description | PURPOSE: To evaluate the feasibility of the use of real-time magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided high-dose-rate brachytherapy (HDR-BT) +/– external beam radiation therapy (EBRT) in patients with histologically-proven local relapse after radical prostatectomy. MATERIAL AND METHODS: We retrospectively reviewed 13 patients treated with real-time MRI-TRUS fusion HDR-BT for a local relapse of prostate cancer after radical surgery. All patients underwent multiparametric magnetic resonance imaging (mpMRI) to confirm the presence of macroscopic lesions in prostate bed, and choline positron emission tomography/computed tomography (PET/CT) to rule out nodal or distant metastases. Local failure was confirmed by transrectal biopsy. Patients without previous EBRT received 1 fraction of 15 Gy with HDR-BT plus hypofractionated EBRT (37.5 Gy in 15 fractions). Two patients received 2 fractions of 12 Gy with HDR-BT without EBRT. Follow-up visits were at 1, 3, 6 months, and every 6 months thereafter. RESULTS: After a median follow-up of 7 months, all patients showed an appropriate biochemical response. Median prostate-specific antigen (PSA) levels before treatment, 1 month, and 6 months after HDR-BT were 2.62 ng/ml (range: 1.55-9.61), 0.97 ng/ml (range: 0.12-3.14), 0.23 ng/ml (range: 0.1-0.74), respectively. Five patients (42%) experienced acute grade 1 GU toxicity and 1 patient (8%) suffered from grade 2 GU toxicity. Regarding gastrointestinal (GI) toxicity, 5 patients referred grade 1 acute toxicity and 1 grade 2 (proctitis). No late toxicity has been observed so far. CONCLUSIONS: MRI-TRUS fusion guided salvage HDR-BT +/– EBRT is a feasible procedure for patients with local macroscopic relapse in tumor bed after radical prostatectomy. Exquisite selection of patients through mpMRI and choline PET/CT is crucial to avoid overtreatment. A larger number of patients and longer follow-up are required in order to draw more solid conclusions regarding the effectiveness of this strategy. |
format | Online Article Text |
id | pubmed-5241376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-52413762017-01-23 Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy Buchser, David Gomez-Iturriaga, Alfonso Melcon, J. Ignacio Rodriguez Casquero, Francisco Llarena, Roberto Cacicedo, Jon Bilbao, Pedro J Contemp Brachytherapy Original Paper PURPOSE: To evaluate the feasibility of the use of real-time magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided high-dose-rate brachytherapy (HDR-BT) +/– external beam radiation therapy (EBRT) in patients with histologically-proven local relapse after radical prostatectomy. MATERIAL AND METHODS: We retrospectively reviewed 13 patients treated with real-time MRI-TRUS fusion HDR-BT for a local relapse of prostate cancer after radical surgery. All patients underwent multiparametric magnetic resonance imaging (mpMRI) to confirm the presence of macroscopic lesions in prostate bed, and choline positron emission tomography/computed tomography (PET/CT) to rule out nodal or distant metastases. Local failure was confirmed by transrectal biopsy. Patients without previous EBRT received 1 fraction of 15 Gy with HDR-BT plus hypofractionated EBRT (37.5 Gy in 15 fractions). Two patients received 2 fractions of 12 Gy with HDR-BT without EBRT. Follow-up visits were at 1, 3, 6 months, and every 6 months thereafter. RESULTS: After a median follow-up of 7 months, all patients showed an appropriate biochemical response. Median prostate-specific antigen (PSA) levels before treatment, 1 month, and 6 months after HDR-BT were 2.62 ng/ml (range: 1.55-9.61), 0.97 ng/ml (range: 0.12-3.14), 0.23 ng/ml (range: 0.1-0.74), respectively. Five patients (42%) experienced acute grade 1 GU toxicity and 1 patient (8%) suffered from grade 2 GU toxicity. Regarding gastrointestinal (GI) toxicity, 5 patients referred grade 1 acute toxicity and 1 grade 2 (proctitis). No late toxicity has been observed so far. CONCLUSIONS: MRI-TRUS fusion guided salvage HDR-BT +/– EBRT is a feasible procedure for patients with local macroscopic relapse in tumor bed after radical prostatectomy. Exquisite selection of patients through mpMRI and choline PET/CT is crucial to avoid overtreatment. A larger number of patients and longer follow-up are required in order to draw more solid conclusions regarding the effectiveness of this strategy. Termedia Publishing House 2016-12-06 2016-12 /pmc/articles/PMC5241376/ /pubmed/28115952 http://dx.doi.org/10.5114/jcb.2016.64441 Text en Copyright: © 2016 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Buchser, David Gomez-Iturriaga, Alfonso Melcon, J. Ignacio Rodriguez Casquero, Francisco Llarena, Roberto Cacicedo, Jon Bilbao, Pedro Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
title | Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
title_full | Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
title_fullStr | Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
title_full_unstemmed | Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
title_short | Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
title_sort | salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241376/ https://www.ncbi.nlm.nih.gov/pubmed/28115952 http://dx.doi.org/10.5114/jcb.2016.64441 |
work_keys_str_mv | AT buchserdavid salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy AT gomeziturriagaalfonso salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy AT melconjignaciorodriguez salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy AT casquerofrancisco salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy AT llarenaroberto salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy AT cacicedojon salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy AT bilbaopedro salvagehighdoseratebrachytherapyforhistologicallyconfirmedmacroscopiclocalrelapsedprostatecancerafterradicalprostatectomy |